Management of spasticity in adults: practical application of botulinum toxin
Authors:
- 1 February 2006
- journal article
- review article
- Published by Wiley in European Journal of Neurology
- Vol. 13 (s1) , 42-50
Abstract
Spasticity, characterized by increased muscle tone, exaggerated stretch reflexes, and abnormal limb posture, is a common sequel of central nervous system pathology. Historically, medicinal treatments have been of limited efficacy. This review discusses the clinical features of spasticity, the functional and pathological consequences, and treatment. It reviews the most common patterns of spasticity encountered in the upper and lower limbs and focuses on focal treatment of spastic muscles with the three commercially available botulinum toxins Botox®, Dysport®, and Myobloc®/NeuroBloc®. It addresses practical details such as muscle selection and identification, drug dilution, and doses.Keywords
This publication has 52 references indexed in Scilit:
- Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimensNeurological Sciences, 2005
- A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic footNeurological Sciences, 2005
- The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticityDisability and Rehabilitation, 2005
- Treatment Algorithm Overview: BoNT Therapy for PainPain Practice, 2004
- Botulinum toxin in post-stroke patients: stiffness modifications and clinical implicationsJournal of Neurology, 2004
- Functional outcome following Botulinum toxin A injection to reduce spastic equinus in adults with traumatic brain injuryBrain Injury, 2004
- Botulinum toxin (Dysport(R)) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging studyJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Use of botulinum toxin in stroke patients with severe upper limb spasticity.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Botulinum toxin type A in the treatment of upper extremity spasticityNeurology, 1996
- The control of muscle tone, reflexes, and movementNeurology, 1980